Z4R-17987-02356 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-26
Dose 1 — Pfizer-BioNTech
2021-04-16
Dose 2 — Pfizer-BioNTech
2021-04-18
Registered in v-safe
2021-04-19
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Abdominal pain

Adult check-in
2021-04-20
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Abdominal pain

Adult check-in
2021-04-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness

Adult check-in
2021-04-25
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-30
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-16
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-23
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-10-15
Survey response — 6 months, dose 2
MedDRA: Pregnancy — Feeling: Good

Free text: Pregnant

MedDRA releases: 2024-11 · check-in free text available
2022-04-16
Survey response — 12 months, dose 2
MedDRA: Pregnancy — Feeling: Good

Free text: Pregnancy

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-26	Pfizer-BioNTech
2	2021-04-16	Pfizer-BioNTech

Free text

Release 10 — 6 months, dose 2

2021-10-15

Symptoms: Pregnant

Release 11 — 12 months, dose 2

2022-04-16

Symptoms: Pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Pregnancy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release